FDA issued a Warning Letter to Hospira, Inc. on 3/7/2014 for a later inspection.
483 Hospira a Pfizer Company Mar 2013

483 Hospira a Pfizer Company Mar 2013

Thomas Arista FDA, Jason Chancey FDA, Viviana Matta FDA, Penny Mccarver FDA, Tammara Stephens FDA$119.00 - Available Now

FDA investigators audited the Hospira a Pfizer Company - Rocky Mount, NC, United States facility and issued 20 inspectional observations (via FDA 483) on 01 Mar 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 20
  • Inspection end: 01 Mar 2013
  • Location: Rocky Mount, United States
  • FEI: 1021343
Add To Cart